Respiratory syncytial virus infection

Respiratory syncytial virus (RSV) is a respiratory illness in both children and adults. Discover the latest research on RSV here.

August 14, 2020
Open Access

The developing T-cell compartment of the neonatal lung orchestrates an atypical response to respiratory syncytial virus

BioRxiv : the Preprint Server for Biology
T. DemoulinsMarco P Alves
September 8, 2020

Clinical manifestations and outcomes of respiratory syncytial virus infection in children less than two years in Colombia

Indian Pediatrics
Jefferson Antonio BuendiaDiana Guerrero Patino
August 18, 2020
Open Access

Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: Implication of universal masking in hospitals

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Shuk-Ching WongVincent Chi-Chung Cheng
September 5, 2020
Case Report
Open Access

Organizing pneumonia secondary to Pneumocystis jirovecii infection in a kidney transplant recipient: Case report and review of literature

Lung India : Official Organ of Indian Chest Society
Rakesh KodatiRavindranath Tagore
September 15, 2020

Airway gene expression correlates of RSV disease severity and microbiome composition in infants

The Journal of Infectious Diseases
Chin-Yi ChuThomas J Mariani
September 21, 2020

Epidemiological and clinical characteristics of children with acute respiratory viral infections in Philippines: a prospective cohort study

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Yuki FuruseHitoshi Oshitani
August 9, 2020

Innate and adaptive immune responses in respiratory virus infection: implications for the clinic

Expert Review of Respiratory Medicine
John StambasRalph A Tripp
August 15, 2020

Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)

The Journal of Infectious Diseases
Kimberley JefferiesRespiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
September 16, 2020

Evaluation of nafamostat mesylate safety and inhibition of SARS-CoV-2 replication using a 3-dimensional human airway epithelia model

BioRxiv : the Preprint Server for Biology
Lynn Kirkpatrick, J. Millard
August 13, 2020
Open Access

Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand

Influenza and Other Respiratory Viruses
Puneyavee AikphaibulThanyawee Puthanakit

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.


Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

© 2020 Meta ULC. All rights reserved